1. Targeting Gli transcription activation by small molecule suppresses tumor growth.
- Author
-
Bosco-Clément, G, Zhang, F, Chen, Z, Zhou, H-M, Li, H, Mikami, I, Hirata, T, Yagui-Beltran, A, Lui, N, Do, H, Cheng, T, Tseng, H-H, Choi, H, Fang, L-T, Kim, I-J, Yue, D, Wang, C, Zheng, Q, Fujii, N, He, B, Jablons, David, and Mann, Michael
- Subjects
Animals ,Cell Line ,Tumor ,Cell Proliferation ,Female ,HCT116 Cells ,HEK293 Cells ,HT29 Cells ,Hedgehog Proteins ,Humans ,Immunoblotting ,Mice ,Mice ,Nude ,NIH 3T3 Cells ,Neoplasms ,Oligonucleotide Array Sequence Analysis ,Protein Binding ,Pyrazoles ,RNA Interference ,Reverse Transcriptase Polymerase Chain Reaction ,Small Molecule Libraries ,TATA-Binding Protein Associated Factors ,Transcription Factor TFIID ,Transcription Factors ,Transcriptional Activation ,Transcriptome ,Tumor Burden ,Xenograft Model Antitumor Assays ,Zinc Finger Protein GLI1 - Abstract
Targeted inhibition of Hedgehog signaling at the cell membrane has been associated with anticancer activity in preclinical and early clinical studies. Hedgehog signaling involves activation of Gli transcription factors that can also be induced by alternative pathways. In this study, we identified an interaction between Gli proteins and a transcription coactivator TBP-associated factor 9 (TAF9), and validated its functional relevance in regulating Gli transactivation. We also describe a novel, synthetic small molecule, FN1-8, that efficiently interferes with Gli/TAF9 interaction and downregulate Gli/TAF9-dependent transcriptional activity. More importantly, FN1-8 suppresses cancer cell proliferation in vitro and inhibits tumor growth in vivo. Our results suggest that blocking Gli transactivation, an important control point of multiple oncogenic pathways, may be an effective anticancer strategy.
- Published
- 2014